Account
pricing market access
Newsletter

PMA Insights: Week 50

15/12/2022

UK:

  • COVID-19 treatment guidance
  • Lung cancer treatments
  • Otsuka Lupkynis MHRA authorisation
  • Stem cell transplants for multiple sclerosis

Germany:

  • IQWiG proposes changes to its general methods with a focus on cost benefit assessment

France:

  • Launch of national registry for Alzheimer’s clinical trials and studies

Europe:

  • Call to action on antimicrobial resistance from MEPs

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.